|
Valemetostat Clinical Trials
4 actively recruiting trials across 4 locations
Also known as: DS-3201, Valemetostat (DS-3201), Valemetostat tosylate
Pipeline
Phase 1: 2Phase 1/2: 2
Top Sponsors
- University of Alabama at Birmingham1
- Memorial Sloan Kettering Cancer Center1
- M.D. Anderson Cancer Center1
- Daiichi Sankyo1
Indications
- Cancer4
- Liver Disease1
- Metastatic Castration-resistant Prostate Cancer1
- Lymphoma1
- Extensive Stage-small Cell Lung Cancer1
Birmingham, Alabama1 trial
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
University of Alabama at Birmingham
Phase 1/2
Basking Ridge, New Jersey1 trial
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Phase 1
Myrtle Beach, South Carolina1 trial
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Carolina Urologic Research Center
Phase 1
Houston, Texas1 trial
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
M D Anderson Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.